semaglutide patent india With semaglutide's expiring, generics are set to enter from soon, setting off competition in a fast-growing segment of obesity and diabetes care. https://timesofindia.indiatimes.com/toi-plus/business-economy/why-miracle-weight-loss-drugs-are Since the patent for semaglutide,

How Mounjaro works Mounjaro mimics two hormones: Like Ozempic, it activates the GLP-1 receptor It also activates a second receptor called GIP (glucose-dependent insulinotropic polypeptide) This dual-action mechanism likely explains why Mounjaro produces greater weight loss and improvements in blood sugar in clinical trials

Beta cell aging markers have heterogeneous distribution and are induced by insulin resistance

Long-acting glucagon-like peptide-1 receptor agonists: a review of their efficacy and tolerability

These effects are usually most noticeable when first starting or increasing doses, though they often improve as your body adjusts

Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class and works in response to elevated blood glucose levels